Article
Serum 25-hydroxyvitamin D levels correlate with EGFR mutational status in pulmonary adenocarcinoma.
Endocrine-related cancer - 1 Oct 2014
Shin Dong-Yeop, Kim Soyeun, Park Sunhoo, Koh Jae Soo, Kim Cheol Hyeon, Baek HeeJong, Yang Sung Hyun, Na Im Il
Abstract excerpt
There have been several epidemiological studies of the association between 25-hydroxyvitamin D (25(OH)D) level and lung cancer risk. We explored the potential association between serum 25(OH)D levels and mutations in epidermal growth factor receptor (EGFR) in patients with pulmonary adenocarcinoma. We analyzed clinical data from 135 patients whose serum 25(OH)D levels were measured and EGFR mutational status was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
